Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN65486961
ISRCTN65486961
Completed
Not Applicable

Pulmonary embolism diagnosis study

Queen Elizabeth II Health Science Centre (Nova Scotia) (Canada)0 sites1,530 target enrollmentSeptember 26, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Queen Elizabeth II Health Science Centre (Nova Scotia) (Canada)
Enrollment
1530
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 26, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Queen Elizabeth II Health Science Centre (Nova Scotia) (Canada)

Eligibility Criteria

Inclusion Criteria

  • •Consecutive adult patients (18 years and older) of either sex, presenting with symptoms or signs suspected by a physician of being caused by acute pulmonary embolism (acute onset of new or worsening shortness of breath, chest pain, hemoptysis, presyncope or syncope) will be potentially eligible for this study.

Exclusion Criteria

  • •1\. Deep vein thrombosis or pulmonary embolism within the previous 3 months
  • •2\. No worsening of the severity of pulmonary symptoms within the previous 2 weeks
  • •3\. Use of therapeutic doses of parenteral anticoagulants for greater than 48 hours
  • •4\. Co\-morbid condition making life expectancy less than 3 months
  • •5\. Contradiction to contrast media
  • •6\. A need for long\-term use of anticoagulants
  • •7\. Pregnancy
  • •8\. Age less than 18 years
  • •9\. Refusal to give informed consent
  • •10\. Geographic inaccessibility to follow\-up

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
PEITHO Pulmonary Embolism THrOmbolysis Study Thrombolysis in Acute Pulmonary EmbolismPatients with intermediate severity pulmonary embolismMedDRA version: 20.0 Level: LLT Classification code 10014521 Term: Embolism pulmonary System Organ Class: 100000004855Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2006-005328-18-PTASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)1,000
Recruiting
Not Applicable
A Study To Determine Alternate Diagnoses To Pulmonary EmbolismHealth Condition 1: R918- Other nonspecific abnormal findingof lung field
CTRI/2021/03/031839St Johns Medical College Hopital
Not yet recruiting
Not Applicable
The incidence of pulmonary embolism in patients undergoing abdominal flap breast reconstructions, a prospective study.bloodclot in the lungsthrombus in the lungs100062321000629510014523
NL-OMON41914Erasmus MC, Universitair Medisch Centrum Rotterdam422
Active, not recruiting
Phase 1
A
EUCTR2006-005328-18-ITASSISTANCE PUBLIQUE HÔPITAUX DE PARIS/ DE`LE`GATION A` LA RECHERCHE CLINIQUE ET AU DE`VELOPPEMENT1,000
Active, not recruiting
Phase 1
PEITHO Pulmonary EmbolIsm THrOmbolysis Study. A prospective, randomized, double-blind, placebo-controlled, international, multicentre, parallel-group comparison trial evaluating the efficacy and safety of single i.v. bolus tenecteplase plus standard anticoagulation as compared with standard anticoagulation in normotensive patients with acute pulmonary embolism and with echocardiographic (or spiral CT) and laboratory evidence of right ventricular dysfunction. - PEITHOPatients atteints d'embolie pulmonaire de gravité intermédiaire
EUCTR2006-005328-18-BEASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)1,000